Latest Breaking News On - Novel antithrombotic - Page 1 : comparemela.com

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT), a clinical-stage biotechnology company developing an innovative drug for the treatment of cardiovascular emergencies,announces today the

Newton biocapitalMikael mazighiVenture investmentEuropean stroke organisation conferenceFrench national institute of healthEuropean stroke organisationRegulatory newsFriday mayProfessor mikael mazighiCoordinating investigatorCeremony large clinical trialsNovel antithromboticReduced intracranial hemorrhageMortality ratesStandard of care reperfusion therapiesFrench national institute